Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
4.790
-0.210 (-4.20%)
At close: Sep 15, 2025, 4:00 PM EDT
4.790
0.00 (0.00%)
After-hours: Sep 15, 2025, 7:53 PM EDT
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $665.41 million as of September 15, 2025. Its market cap has decreased by -41.68% in one year.
Market Cap
665.41M
Enterprise Value
163.01M
1-Year Change
-41.68%
Ranking
Category
Stock Price
$4.79
Market Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has decreased from $1.53B to $665.41M, a decrease of -56.62%. That is a compound annual growth rate of -13.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 694.58M | -31.29% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | 3.41B | 147.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 672.36B |
| Johnson & Johnson | 427.07B |
| AbbVie | 382.69B |
| UnitedHealth Group | 315.85B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 229.57B |